Terms: = Colorectal cancer AND IRF4, LSIRF, 3662, ENSG00000137265, Q15306 AND Treatment
5 results:
1. [Short-course radiotherapy combined with CAPOX and PD-1 inhibitor for the total neoadjuvant therapy of locally advanced rectal cancer: the preliminary single-center findings of a prospective, multicentre, randomized phase II trial (TORCH)].
Wang YQ; Shen LJ; Wan JF; Zhang H; Wang Y; Wu X; Wang JW; Wang RJ; Sun YQ; Tong T; Huang D; Wang L; Sheng WQ; Zhang X; Cai GX; Xu Y; Cai SJ; Zhang Z; Xia F
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):448-458. PubMed ID: 37217353
[No Abstract] [Full Text] [Related]
2. Pre-existing chronic kidney disease and hypertension increased the risk of cardiotoxicity among colorectal cancer patients treated with anticancer drugs.
Ho CC; Wen PC; Yu WC; Hu YW; Yang CC
J Chin Med Assoc; 2021 Sep; 84(9):877-884. PubMed ID: 34320515
[TBL] [Abstract] [Full Text] [Related]
3. Excision Repair Cross-complementation Group 1 is a Prognostic Biomarker in Patients with colorectal cancer Receiving Chemotherapy.
Li MX; Bi XY; Zhao H; Huang Z; Han Y; Zhao DB; Zhao JJ; Cai JQ
Chin Med J (Engl); 2016 Mar; 129(5):586-93. PubMed ID: 26904994
[TBL] [Abstract] [Full Text] [Related]
4. A panel of genes methylated with high frequency in colorectal cancer.
Mitchell SM; Ross JP; Drew HR; Ho T; Brown GS; Saunders NF; Duesing KR; Buckley MJ; Dunne R; Beetson I; Rand KN; McEvoy A; Thomas ML; Baker RT; Wattchow DA; Young GP; Lockett TJ; Pedersen SK; Lapointe LC; Molloy PL
BMC Cancer; 2014 Jan; 14():54. PubMed ID: 24485021
[TBL] [Abstract] [Full Text] [Related]
5. Liability of the voltage-gated sodium channel gene SCN2A R19K polymorphism to oxaliplatin-induced peripheral neuropathy.
Argyriou AA; Antonacopoulou AG; Scopa CD; Kottorou A; Kominea A; Peroukides S; Kalofonos HP
Oncology; 2009; 77(3-4):254-6. PubMed ID: 19738391
[TBL] [Abstract] [Full Text] [Related]
